Stay updated on Long-term Bydureon Use Clinical Trial
Sign up to get notified when there's something new on the Long-term Bydureon Use Clinical Trial page.

Latest updates to the Long-term Bydureon Use Clinical Trial page
- Check4 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.8.0 to v3.8.1.SummaryDifference0.0%

- Check11 days agoChange DetectedThe record describes AstraZeneca’s completed observational study of long-term Bydureon use in Japanese patients with type 2 diabetes, including its eligibility criteria, study locations, and safety and efficacy measures. It also provides study dates, enrollment details, and investigator information.SummaryDifference55%

- Check18 days agoChange DetectedThe footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check32 days agoChange DetectedA general NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” was added above the site header. The footer revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check46 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page now displays a 403 Forbidden error with a simple header and a Home link, replacing the prior study-record content and navigation. This indicates access is blocked to the page rather than a content update.SummaryDifference16%

Stay in the know with updates to Long-term Bydureon Use Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-term Bydureon Use Clinical Trial page.